Found 26 results
Author [ Keyword(Desc)] Title Type Year
Filters: Author is van Breemen, Richard  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
4-Hydroxycoumarins
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Animals
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Anticoagulants
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Blood Coagulation
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Cell Line, Tumor
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Cytochrome P-450 Enzyme Inducers
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Enterohepatic Circulation
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Fat Emulsions, Intravenous
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Half-Life
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Hemorrhage
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Humans
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Inactivation, Metabolic
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Lethal Dose 50
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Male
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Mitochondria
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Neurons
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Rabbits
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Rats
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Rats, Sprague-Dawley
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Rodenticides
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Stereoisomerism
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.

Pages